• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatrics . Test-to-Stay After Exposure to SARS-CoV-2 in K-12 Schools

tetano

Editor, Senior Moderator
Pediatrics


. 2022 Apr 19;e2021056045.
doi: 10.1542/peds.2021-056045. Online ahead of print.
Test-to-Stay After Exposure to SARS-CoV-2 in K-12 Schools


Melissa M Campbell[SUP] 1 2 [/SUP], Daniel K Benjamin[SUP] 1 2 3 [/SUP], Tara Mann[SUP] 1 [/SUP], Alex Fist[SUP] 1 [/SUP], Hwasoon Kim[SUP] 1 [/SUP], Laura Edwards[SUP] 1 [/SUP], Zsolt Rak[SUP] 1 [/SUP], M Alan Brookhart[SUP] 4 [/SUP], Kevin Anstrom[SUP] 1 [/SUP], Zack Moore[SUP] 5 [/SUP], Elizabeth Cuervo Tilson[SUP] 5 [/SUP], Ibukunoluwa C Kalu[SUP] 1 2 [/SUP], Angelique E Boutzoukas[SUP] 1 2 [/SUP], Ganga S Moorthy[SUP] 1 2 [/SUP], Diya Uthappa[SUP] 6 [/SUP], Zeni Scott[SUP] 2 [/SUP], David J Weber[SUP] 7 [/SUP], Andi L Shane[SUP] 8 [/SUP], Kristina A Bryant[SUP] 9 [/SUP], Kanecia O Zimmerman[SUP] 1 2 3 [/SUP]



Affiliations

Abstract

Objectives: We evaluated the safety and efficacy of a test-to-stay program for unvaccinated students and staff who experienced an unmasked, in-school exposure to someone with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Serial testing instead of quarantine was offered to asymptomatic contacts. We measured secondary and tertiary transmission rates within participating schools and in-school days preserved for participants.
Methods: Participating staff or students from universally masked districts in North Carolina underwent rapid antigen testing at set intervals up to 7 days after known exposure. Collected data included location or setting of exposure, participant symptoms, and school absences up to 14 days after enrollment. Outcomes included tertiary transmission, secondary transmission, and school days saved among test-to-stay participants. A prespecified interim safety analysis occurred after 1 month of enrollment.
Results: We enrolled 367 participants and completed 14-day follow-up on all participants for this analysis. Nearly all (215 of 238, 90%) exposure encounters involved an unmasked index case and an unmasked close contact, with most (353 of 366, 96%) occurring indoors, during lunch (137 of 357, 39%) or athletics (45 of 357, 13%). Secondary attack rate was 1.7% (95% confidence interval: 0.6%-4.7%) based on 883 SARS-CoV-2 serial rapid antigen tests with results from 357 participants; no tertiary cases were identified, and 1628 (92%) school days were saved through test-to-stay program implementation out of 1764 days potentially missed.
Conclusion: After unmasked in-school exposure to SARS-CoV-2, even in a mostly unvaccinated population, a test-to-stay strategy is a safe alternative to quarantine.
 
Back
Top Bottom